Charles River Laboratories International, Inc.
CRL
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufactuā¦ read more
Healthcare
Diagnostics & Research
24 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$156.68
Price+0.57%
$0.88
1Y
Price
Market Cap
$7.711b
Mid
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years+20.8%
EBITDA Margin+6.8%
Net Profit Margin+21.1%
Free Cash Flow MarginRevenue
$4.029b
-1.7%
1y CAGR+4.8%
3y CAGR+8.9%
5y CAGREarnings
-$69.225m
-13.0%
1y CAGR+3.0%
3y CAGR+4.1%
5y CAGREPS
-$1.33
-12.1%
1y CAGR+3.3%
3y CAGR+3.9%
5y CAGRBook Value
$3.400b
$7.561b
Assets$4.161b
Liabilities$2.786b
DebtDebt to Assets
36.9%
2.8x
Debt to EBITDAFree Cash Flow
$578.495m
+53.4%
1y CAGR+10.9%
3y CAGR+18.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company